MiR-100对肝癌细胞有丝分裂阻滞及Polo样激酶1蛋白表达的作用

范秉琳 嵇晓辉 朱武凌*

doi:10.3969/j.issn.0529-1356.2014.01.013

解剖学报 ›› 2014, Vol. 45 ›› Issue (1) : 70-73. DOI: 10.3969/j.issn.0529-1356.2014.01.013

肿瘤生物学

MiR-100对肝癌细胞有丝分裂阻滞及Polo样激酶1蛋白表达的作用

范秉琳¹嵇晓辉²朱武凌^1*

作者信息 +

Effects of microRNA-100 on mitosis block and Polo-like kinase 1 expression in hepatocellular carcinoma cells

FAN Bing-lin¹ JI Xiao-hui² ZHU Wu-ling ^1*

Author information +

文章历史 +

摘要

目的探讨microRNA-100（miR-100）对肝癌细胞有丝分裂阻滞及Polo样激酶1 （PLK1) 表达的作用。方法采用实时定量PCR和免疫荧光方法检测miR-100和PLK1在人肝癌细胞HepG2中的表达。利用Oligofectamine脂质体介导将Cy3荧光标记的miR-100模拟物瞬时转染HepG2细胞，分析细胞有丝分裂和PLK1蛋白表达情况。结果肝癌细胞HepG2的miR-100表达量低于正常肝细胞，而PLK1 mRNA和蛋白表达却异常升高。在miR-100模拟物转染后48h，实验组细胞有丝分裂指数显著小于对照细胞，经Western blotting分析显示，实验组细胞PLK1蛋白表达水平较对照组细胞均显著减低。同时免疫细胞化学检测发现，在有丝分裂中晚期和末期位于细胞核内的PLK1蛋白基本消失。结论 miR-100具有抑制PLK1蛋白表达的作用，可引起肝癌细胞有丝分裂阻滞。

Abstract

Objective To investigate the effect of microRNA-100(miR-100) on mitosis block and Polo-likekinase 1(PLK1) expression in hepatocellular carcinoma cells. Methods Expression of miR-100 and PLK1 was determined by quantitative real-time PCR (qRT-PCR) and immunofluorescence (IF) in hepatocellular carcinoma HepG2 cells. HepG2 cells were transiently transfected by miR-100 mimic with Cy3 fluorescence labeled through Oligofectamine liposomes, followed by cell mitosis and PLK1 expression analysis. Results Expression level of miR-100 decreased whereas PLK1 mRNA and protein expression abnormally increased in HepG2 cells compared with the normal hepatocytes. At 48hours after transfection of miR-100 mimic, the mitotic index of HepG2 cells in experimental group was significantly less than that of control cells. Western blotting analysis indicated that PLK1 protein expression levels were significantly reduced in experimental cells compared with the control cells. Immunocytochemical results showed that PLK1 protein in the nucleus almost disappeared in meta/ana-phase and telophase of mitosis. Conclusion MiR-100 may inhibit the expression of PLK1 protein, which leads to mitotic block of hepatocellular carcinoma cells.

导出引用

范秉琳嵇晓辉朱武凌*. MiR-100对肝癌细胞有丝分裂阻滞及Polo样激酶1蛋白表达的作用[J]. 解剖学报. 2014, 45(1): 70-73 https://doi.org/10.3969/j.issn.0529-1356.2014.01.013

FAN Bing-lin JI Xiao-hui ZHU Wu-ling*. Effects of microRNA-100 on mitosis block and Polo-like kinase 1 expression in hepatocellular carcinoma cells[J]. Acta Anatomica Sinica. 2014, 45(1): 70-73 https://doi.org/10.3969/j.issn.0529-1356.2014.01.013

参考文献

［1］Peng DX, Luo M, Qiu LW, et al. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer ［J］. Oncol Rep, 2012, 27(4):1238-1244.
［2］Leite KR, Tomiyama A, Reis ST, et al. MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer ［J］. J Urol, 2011, 185(3):1118-1122.
［3］Di J, Bai ShL, Zhang LZh, et al. Expression of Polo-like kinase 1 during the differentiation of cardiomyocytes in rats ［J］. Acta Anatomica Sinica, 2008, 39(4):578-581. (in Chinese)
邸菁, 柏树令, 张凌志, 等. Polo 样激酶1 在大鼠心肌细胞分化过程中的表达［J］. 解剖学报, 2008, 39(4):578-581. 
［4］Li BH, Zhou JS, Ye F, et al. Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein ［J］. Eur J Cancer, 2011, 47(14): 2166-2174.
［5］Ng WL, Yan D, Zhang X, et al. Over-expression of miR-100 is responsible for the low- expression of ATM in the human glioma cell line: M059J ［J］. DNA Repair, 2010, 9(11): 1170-1175.
［6］de Oliveira JC, Scrideli CA, Brassesco MS, et al. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features［J］. Leuk Res, 2012, 36(3):29329-29338.
［7］Lera RF, Burkard ME.High mitotic activity of Polo-like kinase 1 is required for chromosome segregation and genomic integrity in human epithelial cells［J］. J Biol Chem, 2012, 287(51): 42812-42825.
［8］Pellegrino R, Calvisi DF, Ladu S, et al. Oncogenic and tumor suppressive roles of Polo-like kinases in human hepatocellular carcinoma ［J］. Hepatology, 2010, 51(3): 857-868.［9］He Z, Wu J, Dang H, et al. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of survivin expression ［J］. Cancer Lett, 2011, 303(2):92-98.
［10］Han DP, Zhu QL, Cui JT, et al. Polo-like kinase 1 is overex-pressed in colorectal cancer and participates in the migration and in-vasion of colorectal cancer cells ［J］. Med Sci Monit, 2012, 18(6):237-246.
［11］Reagan-Shaw S, Ahmad N. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer ［J］. FASEB J, 2005, 19(6): 611-613.
［12］de Oliveira JC, Brassesco MS, Pezuk JA, et al. In vitro PLK1 inhibition by BI 2536 decreases proliferation and induces cell-cycle arrest in melanoma cells ［J］. J Drugs Dermatol, 2012, 11(5):5875-5892.